Soren Acquisition Corp. Class A Ordinary Shares(SORN)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 115 days
PROFIT SINCE LAST BUY
+1.71% ▲
LAST CLOSE
$10.11
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SORN

11/13/2026: SORN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Soren Acquisition Corp. is a blank check company formed in 2025 to pursue a merger or acquisition, specifically within the healthcare industry. As a SPAC, its primary strength lies in its $253 million capital pool and an experienced management team dedicated to sourcing growth-stage healthcare targets. The core investment story depends entirely on the company's ability to identify and successfully close a business combination. Risks include high competition for quality targets, potential regulatory shifts, and the high execution risk inherent in blank check entities. The stock is a speculative vehicle best suited for growth-oriented investors and should be monitored for any news regarding a definitive merger agreement.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company offers high-risk, high-reward potential tied to the success of an eventual business combination.
Momentum investorMixed fitPrice movement is often driven by speculative news regarding potential acquisition targets.
Value investorWeak fitThe company lacks current earnings or assets to support a traditional value-based valuation model.
Dividend investorWeak fitThe company is not currently structured to provide income-generating dividends.
Low-risk investorWeak fitSPAC investments carry significant execution and volatility risk until a successful merger is closed.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe share price is highly sensitive to news about prospective acquisitions and market sentiment regarding SPACs.
Valuation riskMedium / highThere is uncertainty regarding the valuation of a target company once a deal is announced.
Competition risk (Healthcare SPACs)HighNumerous SPACs are competing for a limited pool of high-quality healthcare targets.
Business qualityMediumQuality depends entirely on the future target company selected by the management team.
Dividend incomeLow / noneThe company has no operations to support dividend payments.
Execution riskHighThe company may fail to find or successfully merge with a target entity, potentially leading to liquidation.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 350.98M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 33.7K shares
Beta -
52 Weeks Range 9.81 - 10.88
Updated Date 11/14/2026
52 Weeks Range 9.81 - 10.88
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) -

Sector & Industry Intelligence

Sector

Financial Services

Constructive
Sentiment
Bullish
Momentum
BUY Breadth Improving
BUY participation
50.4%
Active BUY / eligible
61 / 121
30-Day BUY Count Change
+45
Market state
Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Shell Companies

BUY participation
100.0%
Active BUY / eligible
1 / 1
30-Day BUY Count Change
+1

Eligible universe: 1 stock.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Flat / Range-Bound
PRICE PATH

Flat / Range-Bound

The stock price has been trading within a narrow range with minimal directional movement.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type Stock
Historic Profit 1.71%
Avg. Invested days 115
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SORN receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
SORN has moderate overall fundamentals (3 stars), with moderate financial health, moderate growth momentum, and solid ownership. Growth and ownership metrics are mixed: slightly negative earnings growth (+0.0%), soft cash generation (FCF margin 0.0%), slightly negative revenue growth (+0.0%).

Financial Health Rating

★★★★★
SORN's financial health is supported by strong efficiency, including operating-expense and cost-of-revenue discipline (opex 0.0% of revenue). Profitability is weak (1 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
SORN's growth profile is soft, with the least-weak measure being revenue growth at +0.0% year over year. By comparison, while earnings growth (+0.0%, slightly negative) and free-cash-flow growth (+0.0%, slightly negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 81.3% and approximately 78.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.15%, which materially reduces the ownership score.

Top 5 Institutional Investors

Adage Capital Partners Gp LLC 5.70%
SONA ASSET MANAGEMENT (US) LLC 5.33%
Magnetar Financial LLC 5.04%
Linden Advisors LLC 4.61%
D. E. Shaw & Co LP 3.60%

Unit Economics (Per $1K Revenue)

★★★★★
SORN generates approximately $0 of gross profit, $-0 of operating income, and $0 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
SORN has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Healthcare Acquisition StrategyInvestment of IPO proceeds into a target business in the healthcare sector.The company is a 'blank check' entity; you are essentially betting on the management's ability to pick a good healthcare company to take public.

Valuation

Trailing PE -
Forward PE -
Enterprise Value 349.18M
Price to Sales(TTM) -
Enterprise Value 349.18M
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 26.30M
Shares Floating 20.72M
Shares Outstanding 26.30M
Shares Floating 20.72M
Percent Insiders 0.15
Percent Institutions 81.33

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.